Oracle's Larry Ellison has abandoned a trading arrangement designed to permit him to offload as many as 50 million Oracle shares before 24 October, just one day following its public revelation and without any shares changing hands. The mechanism in question—a Rule 10b5-1 plan—represents an American regulatory tool with no equivalent in Europe, where market abuse regulations take a different approach to executive share dealings.
According to Bloomberg, the company issued a statement confirming that "No Oracle stock was sold under that plan, and he has no other plans to sell any of his Oracle stock."
Ellison initiated the plan on 22 June with an expiration date of 24 October. At the time of adoption, the shares represented approximately $8.75 billion in value, though they had declined to roughly $7.5 billion by the cancellation date, reflecting a 16 percent decrease in share price. Oracle officially designated it as a 10b5-1 plan in its announcement.
The executive maintains approximately 40 percent ownership of Oracle and serves as both executive chair and chief technology officer.
Why the timing mattered
The week surrounding the plan's disclosure proved challenging for the technology company. Oracle announced declining gross margins on Thursday, its stock dropped 1.7 percent on Friday, and simultaneously disclosed that restructuring expenses would reach $2.8 billion.
How American and European rules diverge
A Rule 10b5-1 plan functions as a distinctly American regulatory mechanism with no parallel in European markets. Established in 2000 and subject to enhanced disclosure requirements implemented by the SEC in 2022, this arrangement permits executives who lack material non-public information to schedule trades in advance, allowing transactions to proceed according to a predetermined timetable even during periods when discretionary selling might invite scrutiny.
The European approach operates on an entirely different principle. Under the Market Abuse Regulation, individuals holding managerial responsibilities cannot transact in company shares during the 30 calendar days preceding the release of interim or year-end financial reports. Critically, no advance-adoption exemption exists within this framework.
Disclosure practices also diverge significantly between the two jurisdictions. Europe mandates publication of completed transactions—not advance plans—within three working days of execution, once cumulative trading reaches EUR 5,000 in a calendar year. A plan that generated no actual trades would have remained entirely invisible to the market.
Nothing in these circumstances suggests Ellison acted improperly. The plan was disclosed in full accordance with American regulatory requirements, which explains why the market learned of it in the first place. However, the two regulatory frameworks would have produced markedly different outcomes: European rules would have prevented the plan's existence from becoming public knowledge and would have prohibited its operation during a period encompassing company results.
Source: The Next Web
